Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Source :: Plus Company Updates. July 24, 2024
Publication Year :: 2024
Abstract: SAN JOSE: Anixa Biosciences, Inc. has issued the following news release: Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of [...]

Subjects :: United States. Food and Drug Administration
Cancer patients -- Drug therapy
Cancer -- Care and treatment
Drug approval -- Health aspects
College teachers -- Health aspects
Ovarian cancer -- Drug therapy
General interest
News, opinion and commentary

Tools